APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ceftriaxone Sodium

Ceftriaxone sodium is a cephalosporin antibiotic.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Ceftriaxone sodium is a cephalosporin antibiotic.

Selected research

Market Structure

Global Ceftriaxone Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173976130328 December 2025195 pages

Choose your research edition.

Industry ResearchCeftriaxone Sodium Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceftriaxone Sodium Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Ceftriaxone Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceftriaxone Sodium Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceftriaxone Sodium Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Ceftriaxone sodium is a cephalosporin antibiotic.

There are three kinds of Ceftriaxone Sodium, which are ChP, USP and EP. ChP hold the largest share of the Ceftriaxone Sodium market, with a sales market share nearly 74% in 2019.

Ceftriaxone Sodium is used in Single Injection and Compound Injection. The most proportion of Ceftriaxone Sodium is used in Single Injection, and the market share in 2019 is about 96%.

Read the full market overview

Asia-Pacific is the largest consumption place, with a consumption market share nearly 80% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of about 12%.

For the production, China and India are the mainly manufactured base.

Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, etc. are the leader of the industry, and top 5 players hold about 50% revenue market share.

This report provides an overview of the global Ceftriaxone Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ceftriaxone Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ceftriaxone Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ceftriaxone Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Ceftriaxone Sodium Segment by Company

Shandong Ruiying

Qilu Antibiotics

Nectar Lifesciences

Kelun

United Laboratories

Aurobindo Pharma

Orchid Pharma

Medya Pharma

REYOUNG

LKPC

ACS Dobfar

NCPC

Dawnrays

Kopran

Ceftriaxone Sodium Segment by Type

ChP

USP

EP

Ceftriaxone Sodium Segment by Application

Single Injection

Compound Injection

Ceftriaxone Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceftriaxone Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceftriaxone Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceftriaxone Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ceftriaxone Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceftriaxone Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ceftriaxone Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ceftriaxone Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ceftriaxone Sodium Industry Trends Table 2. Ceftriaxone Sodium Industry Drivers Table 3. Ceftriaxone Sodium Industry Opportunities and Challenges Table 4. Ceftriaxone Sodium Industry Restraints Table 5. Global Ceftriaxone Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ceftriaxone Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ceftriaxone Sodium Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Ceftriaxone Sodium Sales Market Share by Manufacturers Table 9. Global Ceftriaxone Sodium Average Sales Price (USD/Kg) of Manufacturers (2021-2026) Table 10. Global Ceftriaxone Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ceftriaxone Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ceftriaxone Sodium Manufacturers, Product Type & Application Table 13. Global Ceftriaxone Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ceftriaxone Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ChP Table 17. Major Manufacturers of USP Table 18. Major Manufacturers of EP Table 19. Global Ceftriaxone Sodium Sales by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Ceftriaxone Sodium Sales by Type (2021-2026) & (MT) Table 21. Global Ceftriaxone Sodium Sales by Type (2027-2032) & (MT) Table 22. Global Ceftriaxone Sodium Sales Market Share by Type (2021-2026) Table 23. Global Ceftriaxone Sodium Sales Market Share by Type (2027-2032) Table 24. Global Ceftriaxone Sodium Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 25. Global Ceftriaxone Sodium Revenue by Type (2021-2026) & (MT) Table 26. Global Ceftriaxone Sodium Revenue by Type (2027-2032) & (MT) Table 27. Global Ceftriaxone Sodium Revenue Market Share by Type (2021-2026) Table 28. Global Ceftriaxone Sodium Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Single Injection Table 30. Major Manufacturers of Compound Injection Table 31. Global Ceftriaxone Sodium Sales by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global Ceftriaxone Sodium Sales by Application (2021-2026) & (MT) Table 33. Global Ceftriaxone Sodium Sales by Application (2027-2032) & (MT) Table 34. Global Ceftriaxone Sodium Sales Market Share by Application (2021-2026) Table 35. Global Ceftriaxone Sodium Sales Market Share by Application (2027-2032) Table 36. Global Ceftriaxone Sodium Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 37. Global Ceftriaxone Sodium Revenue by Application (2021-2026) & (MT) Table 38. Global Ceftriaxone Sodium Revenue by Application (2027-2032) & (MT) Table 39. Global Ceftriaxone Sodium Revenue Market Share by Application (2021-2026) Table 40. Global Ceftriaxone Sodium Revenue Market Share by Application (2027-2032) Table 41. Global Ceftriaxone Sodium Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 42. Global Ceftriaxone Sodium Sales by Region (2021-2026) & (MT) Table 43. Global Ceftriaxone Sodium Sales Market Share by Region (2021-2026) Table 44. Global Ceftriaxone Sodium Sales Forecasted by Region (2027-2032) & (MT) Table 45. Global Ceftriaxone Sodium Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 47. North America Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 48. North America Ceftriaxone Sodium Sales by Country (2027-2032) & (MT) Table 49. Europe Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 50. Europe Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 51. Europe Ceftriaxone Sodium Sales by Country (2027-2032) & (MT) Table 52. Asia Pacific Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 53. Asia Pacific Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 54. Asia Pacific Ceftriaxone Sodium Sales by Country (2027-2032) & (MT) Table 55. South America, Middle East and Africa Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 56. South America, Middle East and Africa Ceftriaxone Sodium Sales by Country (2021-2026) & (MT) Table 57. South America, Middle East and Africa Ceftriaxone Sodium Sales by Country (2027-2032) & (MT) Table 58. Global Ceftriaxone Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ceftriaxone Sodium Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Ceftriaxone Sodium Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Ceftriaxone Sodium Revenue Market Share by Region (2021-2026) Table 62. Global Ceftriaxone Sodium Revenue Market Share by Region (2027-2032) Table 63. Shandong Ruiying Company Information Table 64. Shandong Ruiying Business Overview Table 65. Shandong Ruiying Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shandong Ruiying Ceftriaxone Sodium Product Portfolio Table 67. Shandong Ruiying Recent Development Table 68. Qilu Antibiotics Company Information Table 69. Qilu Antibiotics Business Overview Table 70. Qilu Antibiotics Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Qilu Antibiotics Ceftriaxone Sodium Product Portfolio Table 72. Qilu Antibiotics Recent Development Table 73. Nectar Lifesciences Company Information Table 74. Nectar Lifesciences Business Overview Table 75. Nectar Lifesciences Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Nectar Lifesciences Ceftriaxone Sodium Product Portfolio Table 77. Nectar Lifesciences Recent Development Table 78. Kelun Company Information Table 79. Kelun Business Overview Table 80. Kelun Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Kelun Ceftriaxone Sodium Product Portfolio Table 82. Kelun Recent Development Table 83. United Laboratories Company Information Table 84. United Laboratories Business Overview Table 85. United Laboratories Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. United Laboratories Ceftriaxone Sodium Product Portfolio Table 87. United Laboratories Recent Development Table 88. Aurobindo Pharma Company Information Table 89. Aurobindo Pharma Business Overview Table 90. Aurobindo Pharma Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Aurobindo Pharma Ceftriaxone Sodium Product Portfolio Table 92. Aurobindo Pharma Recent Development Table 93. Orchid Pharma Company Information Table 94. Orchid Pharma Business Overview Table 95. Orchid Pharma Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Orchid Pharma Ceftriaxone Sodium Product Portfolio Table 97. Orchid Pharma Recent Development Table 98. Medya Pharma Company Information Table 99. Medya Pharma Business Overview Table 100. Medya Pharma Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Medya Pharma Ceftriaxone Sodium Product Portfolio Table 102. Medya Pharma Recent Development Table 103. REYOUNG Company Information Table 104. REYOUNG Business Overview Table 105. REYOUNG Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. REYOUNG Ceftriaxone Sodium Product Portfolio Table 107. REYOUNG Recent Development Table 108. LKPC Company Information Table 109. LKPC Business Overview Table 110. LKPC Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. LKPC Ceftriaxone Sodium Product Portfolio Table 112. LKPC Recent Development Table 113. ACS Dobfar Company Information Table 114. ACS Dobfar Business Overview Table 115. ACS Dobfar Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. ACS Dobfar Ceftriaxone Sodium Product Portfolio Table 117. ACS Dobfar Recent Development Table 118. NCPC Company Information Table 119. NCPC Business Overview Table 120. NCPC Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. NCPC Ceftriaxone Sodium Product Portfolio Table 122. NCPC Recent Development Table 123. Dawnrays Company Information Table 124. Dawnrays Business Overview Table 125. Dawnrays Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Dawnrays Ceftriaxone Sodium Product Portfolio Table 127. Dawnrays Recent Development Table 128. Kopran Company Information Table 129. Kopran Business Overview Table 130. Kopran Ceftriaxone Sodium Sales (MT), Price (USD/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Kopran Ceftriaxone Sodium Product Portfolio Table 132. Kopran Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Ceftriaxone Sodium Distributors List Table 136. Ceftriaxone Sodium Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Ceftriaxone Sodium Product Image Figure 2. Global Ceftriaxone Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceftriaxone Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceftriaxone Sodium Sales (2021-2032) & (MT) Figure 5. Global Ceftriaxone Sodium Average Price (USD/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Ceftriaxone Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ChP Image Figure 9. USP Image Figure 10. EP Image Figure 11. Global Ceftriaxone Sodium Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Ceftriaxone Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Ceftriaxone Sodium Sales Market Share by Type (2021-2032) Figure 14. Global Ceftriaxone Sodium Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 15. Global Ceftriaxone Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Ceftriaxone Sodium Revenue Market Share by Type (2021-2032) Figure 17. Single Injection Image Figure 18. Compound Injection Image Figure 19. Global Ceftriaxone Sodium Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 20. Global Ceftriaxone Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Ceftriaxone Sodium Sales Market Share by Application (2021-2032) Figure 22. Global Ceftriaxone Sodium Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global Ceftriaxone Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ceftriaxone Sodium Revenue Market Share by Application (2021-2032) Figure 25. North America Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 26. North America Ceftriaxone Sodium Sales Market Share by Country (2021-2032) Figure 27. U.S. Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 28. Canada Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 29. Mexico Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 30. Europe Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Ceftriaxone Sodium Sales Market Share by Country (2021-2032) Figure 32. Germany Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 33. France Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 34. U.K. Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 35. Italy Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 36. Netherlands Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 37. Asia Pacific Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Ceftriaxone Sodium Sales Market Share by Country (2021-2032) Figure 39. China Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 40. Japan Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 41. South Korea Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 42. Southeast Asia Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 43. India Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 44. Australia Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 45. South America, Middle East and Africa Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Ceftriaxone Sodium Sales Market Share by Country (2021-2032) Figure 47. Brazil Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 48. South Africa Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 49. Saudi Arabia Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 50. Turkey Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 51. Argentina Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 52. UAE Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 53. Egypt Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 54. Chile Ceftriaxone Sodium Sales and Growth Rate (2021-2032) & (MT) Figure 55. Global Ceftriaxone Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Ceftriaxone Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Ceftriaxone Sodium Revenue (2021-2032) & (US$ Million) Figure 58. North America Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Ceftriaxone Sodium Revenue (2021-2032) & (US$ Million) Figure 60. Europe Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ceftriaxone Sodium Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Ceftriaxone Sodium Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ceftriaxone Sodium Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Ceftriaxone Sodium Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • ChP
  • USP
  • EP
Applications
  • Single Injection
  • Compound Injection
Companies covered
  • Shandong Ruiying
  • Qilu Antibiotics
  • Nectar Lifesciences
  • Kelun
  • United Laboratories
  • Aurobindo Pharma
  • Orchid Pharma
  • Medya Pharma
  • REYOUNG
  • LKPC
  • ACS Dobfar
  • NCPC
  • Dawnrays
  • Kopran

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ceftriaxone Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ceftriaxone Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ceftriaxone Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ceftriaxone Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ceftriaxone Sodium Market Dynamics
  1. 2.1 Ceftriaxone Sodium Industry Trends
  2. 2.2 Ceftriaxone Sodium Industry Drivers
  3. 2.3 Ceftriaxone Sodium Industry Opportunities and Challenges
  4. 2.4 Ceftriaxone Sodium Industry Restraints
3 Ceftriaxone Sodium Market by Manufacturers
  1. 3.1 Global Ceftriaxone Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ceftriaxone Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ceftriaxone Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ceftriaxone Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceftriaxone Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ceftriaxone Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Ceftriaxone Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceftriaxone Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceftriaxone Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceftriaxone Sodium Tier 1, Tier 2, and Tier 3
4 Ceftriaxone Sodium Market by Type
  1. 4.1 Ceftriaxone Sodium Type Introduction
  2. 4.1.1 ChP
  3. 4.1.2 USP
  4. 4.1.3 EP
  5. 4.2 Global Ceftriaxone Sodium Sales by Type
  6. 4.2.1 Global Ceftriaxone Sodium Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ceftriaxone Sodium Sales by Type (2021-2032)
  8. 4.2.3 Global Ceftriaxone Sodium Sales Market Share by Type (2021-2032)
  9. 4.3 Global Ceftriaxone Sodium Revenue by Type
  10. 4.3.1 Global Ceftriaxone Sodium Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Ceftriaxone Sodium Revenue by Type (2021-2032)
  12. 4.3.3 Global Ceftriaxone Sodium Revenue Market Share by Type (2021-2032)
5 Ceftriaxone Sodium Market by Application
  1. 5.1 Ceftriaxone Sodium Application Introduction
  2. 5.1.1 Single Injection
  3. 5.1.2 Compound Injection
  4. 5.2 Global Ceftriaxone Sodium Sales by Application
  5. 5.2.1 Global Ceftriaxone Sodium Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ceftriaxone Sodium Sales by Application (2021-2032)
  7. 5.2.3 Global Ceftriaxone Sodium Sales Market Share by Application (2021-2032)
  8. 5.3 Global Ceftriaxone Sodium Revenue by Application
  9. 5.3.1 Global Ceftriaxone Sodium Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ceftriaxone Sodium Revenue by Application (2021-2032)
  11. 5.3.3 Global Ceftriaxone Sodium Revenue Market Share by Application (2021-2032)
6 Global Ceftriaxone Sodium Sales by Region
  1. 6.1 Global Ceftriaxone Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ceftriaxone Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Ceftriaxone Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Ceftriaxone Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ceftriaxone Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ceftriaxone Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ceftriaxone Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ceftriaxone Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ceftriaxone Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ceftriaxone Sodium Revenue by Region
  1. 7.1 Global Ceftriaxone Sodium Revenue by Region
  2. 7.1.1 Global Ceftriaxone Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ceftriaxone Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Ceftriaxone Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Ceftriaxone Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ceftriaxone Sodium Revenue (2021-2032)
  8. 7.2.2 North America Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ceftriaxone Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ceftriaxone Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ceftriaxone Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ceftriaxone Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Ruiying
  2. 8.1.1 Shandong Ruiying Company Information
  3. 8.1.2 Shandong Ruiying Business Overview
  4. 8.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Ruiying Ceftriaxone Sodium Product Portfolio
  6. 8.1.5 Shandong Ruiying Recent Developments
  7. 8.2 Qilu Antibiotics
  8. 8.2.1 Qilu Antibiotics Company Information
  9. 8.2.2 Qilu Antibiotics Business Overview
  10. 8.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Portfolio
  12. 8.2.5 Qilu Antibiotics Recent Developments
  13. 8.3 Nectar Lifesciences
  14. 8.3.1 Nectar Lifesciences Company Information
  15. 8.3.2 Nectar Lifesciences Business Overview
  16. 8.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Portfolio
  18. 8.3.5 Nectar Lifesciences Recent Developments
  19. 8.4 Kelun
  20. 8.4.1 Kelun Company Information
  21. 8.4.2 Kelun Business Overview
  22. 8.4.3 Kelun Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kelun Ceftriaxone Sodium Product Portfolio
  24. 8.4.5 Kelun Recent Developments
  25. 8.5 United Laboratories
  26. 8.5.1 United Laboratories Company Information
  27. 8.5.2 United Laboratories Business Overview
  28. 8.5.3 United Laboratories Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 United Laboratories Ceftriaxone Sodium Product Portfolio
  30. 8.5.5 United Laboratories Recent Developments
  31. 8.6 Aurobindo Pharma
  32. 8.6.1 Aurobindo Pharma Company Information
  33. 8.6.2 Aurobindo Pharma Business Overview
  34. 8.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Portfolio
  36. 8.6.5 Aurobindo Pharma Recent Developments
  37. 8.7 Orchid Pharma
  38. 8.7.1 Orchid Pharma Company Information
  39. 8.7.2 Orchid Pharma Business Overview
  40. 8.7.3 Orchid Pharma Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Orchid Pharma Ceftriaxone Sodium Product Portfolio
  42. 8.7.5 Orchid Pharma Recent Developments
  43. 8.8 Medya Pharma
  44. 8.8.1 Medya Pharma Company Information
  45. 8.8.2 Medya Pharma Business Overview
  46. 8.8.3 Medya Pharma Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medya Pharma Ceftriaxone Sodium Product Portfolio
  48. 8.8.5 Medya Pharma Recent Developments
  49. 8.9 REYOUNG
  50. 8.9.1 REYOUNG Company Information
  51. 8.9.2 REYOUNG Business Overview
  52. 8.9.3 REYOUNG Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 REYOUNG Ceftriaxone Sodium Product Portfolio
  54. 8.9.5 REYOUNG Recent Developments
  55. 8.10 LKPC
  56. 8.10.1 LKPC Company Information
  57. 8.10.2 LKPC Business Overview
  58. 8.10.3 LKPC Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LKPC Ceftriaxone Sodium Product Portfolio
  60. 8.10.5 LKPC Recent Developments
  61. 8.11 ACS Dobfar
  62. 8.11.1 ACS Dobfar Company Information
  63. 8.11.2 ACS Dobfar Business Overview
  64. 8.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ACS Dobfar Ceftriaxone Sodium Product Portfolio
  66. 8.11.5 ACS Dobfar Recent Developments
  67. 8.12 NCPC
  68. 8.12.1 NCPC Company Information
  69. 8.12.2 NCPC Business Overview
  70. 8.12.3 NCPC Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 NCPC Ceftriaxone Sodium Product Portfolio
  72. 8.12.5 NCPC Recent Developments
  73. 8.13 Dawnrays
  74. 8.13.1 Dawnrays Company Information
  75. 8.13.2 Dawnrays Business Overview
  76. 8.13.3 Dawnrays Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dawnrays Ceftriaxone Sodium Product Portfolio
  78. 8.13.5 Dawnrays Recent Developments
  79. 8.14 Kopran
  80. 8.14.1 Kopran Company Information
  81. 8.14.2 Kopran Business Overview
  82. 8.14.3 Kopran Ceftriaxone Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kopran Ceftriaxone Sodium Product Portfolio
  84. 8.14.5 Kopran Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ceftriaxone Sodium Value Chain Analysis
  2. 9.1.1 Ceftriaxone Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ceftriaxone Sodium Production Mode & Process
  6. 9.2 Ceftriaxone Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ceftriaxone Sodium Distributors
  9. 9.2.3 Ceftriaxone Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst